Across TCGA pan-cancer cohorts, MIR1268A RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MIR1268A’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where MIR1268A RNA is repressed in tumor relative to normal tissue. In most cancer types MIR1268A is over-expressed in tumor, although a few such as COAD show the opposite, repressed pattern.

COAD, PAAD, and LIHC are the cancer types where MIR1268A tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR1268A RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	Female	All	−1.083	<.001	7	view →
PAAD	Male	All	+1.450	.009	4	view →
LIHC	Female	III,IV	+0.612	.038	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: MIR1268A RNA expression & survival · all MIR1268A data types